Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study

Cancer Research

Volumn 61, Issue 18, 2001, Pages 6708-6712

  Tang, Deliang ^a   Phillips, David H ^b   Stampfer, Meir ^c   Mooney, LaVerne A ^a   Hsu, Yanzhi ^a   Cho, Stan ^a   Tsai, Wei Yann ^a   Ma, Jing ^c   Cole, Kathleen J ^b   Shé, Meadhbh Ni ^b   Perera, Frederica P ^a  

^a Columbia University ^*  (United States)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; DNA; NUCLEASE; NUCLEASE P1; PHOSPHORUS 32; POLYCYCLIC AROMATIC HYDROCARBON; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DNA ADDUCT; DNA DAMAGE; HUMAN; HUMAN CELL; LEUKOCYTE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; TOBACCO;

CARCINOGENS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CASE-CONTROL STUDIES; DNA ADDUCTS; DNA DAMAGE; HUMANS; LEUKOCYTES; LOGISTIC MODELS; LUNG NEOPLASMS; MIDDLE AGED; POLYCYCLIC HYDROCARBONS, AROMATIC; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0035884642     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Molecular epidemiology: On the path to prevention?
2. Lack of effect of long-term supplementation with β-carotene on the incidence of malignant neoplasms and cardiovascular disease
3. Cancer facts and figures
4. The health consequences of involuntary smoking
5. Tobacco smoke carcinogens and lung cancer
6. Polynuclear aromatic compounds. Part I. Chemical, environmental, and experimental data
7. Standardization and validation of DNA adduct postlabelling methods: Report of interlaboratory trials and production of recommended protocols
8. Mechanisms of chemical carcinogenesis
9. Polycyclic aromatic hydrocarbon-DNA adducts in humans: Relevance as biomarkers for exposure and cancer risk
10. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients
11. A case-control molecular epidemiological study of lung cancer
12. Early age at smoking initiation and tobacco carcinogen DNA damage in the lung
13. Exposure-route-dependent DNA adduct formation by polycyclic aromatic hydrocarbons
14. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
15. Monitoring human exposure to carcinogens by ultrasensitive postlabelling assays: Application to unidentified genotoxicants
16. A pilot project in molecular cancer epidemiology: Determination of benzo[a]pyrene adducts in animal and human tissues by immunoassay
17. Carcinogen macromolecular adducts and their measurement
18. Impact of adduct determination on the assessment of cancer susceptibility
19. Correlation of DNA adducts in blood mononuclear cells with tobacco carcinogen-induced damage in human lung
20. 32P-postlabelling assay
21. DNA adducts, protein adducts and sister chromatid exchange in cigarette smokers and nonsmokers
22. DNA adducts as a measure of lung cancer risk in human exposed to polycyclic aromatic hydrocarbons
23. The role of individual susceptibility in cancer burden related to environmental exposure
24. Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cells
25. Decline on DNA damage and other biomarkers in peripheral blood following smoking cessation
26. Seasonal variation of aryl hydrocarbon hydroxylase activity in human lymphocytes
27. 32P-adduct assay: Comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures
28. 32P-postlabeling of aromatic DNA adducts in white blood cell DNA from foundry workers
29. 32P-postlabelling detection of aromatic DNA adducts in peripheral blood lymphocytes from aluminum production plant workers
30. Smoking-related DNA adducts in human cervical biopsies
31. No effect of an antiaggregant treatment with aspirin in small cell lung cancer treated with CCAVP16 chemotherapy. Results from a randomized clinical trial of 303 patients. The "Pettites Cellules" Group
32. Molecular cancer epidemiology: A new tool in cancer prevention
33. p53 tumor suppressor gene: At the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment
34. From genes to public health: The applications of genetic technology in disease prevention
35. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population
36. Variability in PAH-DNA adduct measurements in peripheral mononuclear cells: Implications for quantitative cancer risk assessment
37. Incorporating biomarkers into cancer epidemiology: A matrix of biomarker and study design categories
38. Contribution of genetic and nutritional factors to DNA damage in heavy smokers
39. Environment and cancer: Who are susceptible?
40. Genetic susceptibility to cancer
41. Markers of DNA repair and susceptibility to cancer in humans: An epidemiologic review
42. DNA adducts as markers of exposure to carcinogens and risk of cancer
43. Modulation of DNA adducts in heavy smokers by genetic factors
44. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People’s Republic of China
45. Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan
46. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan